In vitro evaluation of mutant HSV-1 thymidine kinases for suicide gene therapy

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 959-963

  Kokoris, Mark S ^a   Sabo, Peter ^a   Black, Margaret E ^a,b  

^a Chiroscience R and D Inc   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Acyclovir; Ganciclovir; Suicide gene therapy; Thymidine kinase

Indexed keywords

ACICLOVIR; GANCICLOVIR; MUTANT PROTEIN; THYMIDINE KINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME PHOSPHORYLATION; GENE THERAPY; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE;

ACYCLOVIR; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CELL SURVIVAL; CLONING, MOLECULAR; CRICETINAE; GANCICLOVIR; GENE LIBRARY; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 1, HUMAN; HISTIDINOL; HUMAN GROWTH HORMONE; HUMANS; LUMINESCENT PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; THYMIDINE KINASE; TRANSFECTION;

EID: 0034098464     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Balzarini J, Bohman C, and De Clerq E: Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J Biol Chem 268: 6332-6337, 1993.
2. Chen MS, Walker J and Prusoff WH: Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme. J Biol Chem 254: 10747-10753, 1979.
3. Chen MS, Summers WP, Walker J, Summers WC and Prusoff WH: Characterization of pyrimidine deoxyribonucleoside kinase (thymidine kinase) and thymidylate kinase as a multifunctional enzyme in cells transformed by herpes simplex virus type 1 and in cells infected with mutant strains of herpes simplex virus. J Virol 30: 942-945, 1979.
4. Field AK, Davies ME, DeWitt C, Perry HC, Liou R, Germershausen J, Karkas JD, Ashton WT, Johnston DBR and Tolman RL: 9-([2-hydroxy-1-(hydroxymethyl) ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci USA 80: 4139-4143, 1983.
5. Furman PA, St. Clair MH and Spector T: Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase. J Biol Chem 259: 9575-9579, 1984.
6. Gentry GA: Viral thymidine kinases and their relatives. Pharmacol Ther 54: 319-355, 1992.
7. Boehme RE: Phosphorylation of the antiviral precursor 9-(1,3-dihydroxy-2-propoxymethyl)guanine monophosphate by guanylate kinase isozymes. J Biol Chem 259: 12346-12349, 1984.
8. Miller WH and Miller RL: Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. J Biol Chem 255: 7204-7207, 1980.
9. Reardon JE: Herpes simplex virus type 1 and DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogs. Kinetics of incorporation into DNA and induction of inhibition. J Biol Chem 264: 19039-19044, 1989.
10. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann J-L and Klatzmann D: Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90: 7024-7028, 1993.
11. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH and Blaese RM: In vivo gene transfer with retroviral vector-producing cells for treatment of experimental brain tumors. Science 256: 9575-9579, 1992.
12. Moolten F and Wells JM: Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82: 297-300, 1990.
13. Ram Z, Culver KW, Wallbridge S Jr, Blaese RM and Oldfield EH: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats Cancer Res 53: 83-88, 1993.
14. Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, Oikawa S and Kishimoto T: Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 54: 5258-5261, 1994.
15. Scholz D, Amdt R and Meyer T: Evidence for an immunosuppressive activity of ganciclovir. Transplant Proc 26: 3253-3254, 1994.
16. Bi WL, Parysek LM, Warnick R and Stambrook PJ: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Human Gene Ther 4: 725-731, 1993.
17. Colombo BM, Benedetti S, Ottolenghi S, Mora M, Pollo B, Poli G and Finocchiaro G: The "bystander effect": Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Human Gene Ther 6: 763-772, 1995.
18. Freeman SM, Abboud CN, Whartenbuy KA, Packman CH, Koeplin CS, Moolten FL and Abraham GN: The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274-5283, 1993.
19. Tapscott SJ, Miller AD, Olson JM, Berger MS, Groudine M and Spence AM: Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc Natl Acad Sci USA 91: 8185-8189, 1994.
20. Black ME, Newcomb TG, Wilson H-MP and Loeb LA: Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U.S.A. 93: 3525-3529, 1996.
21. Kokoris MS, Sabo P and Black ME: Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Gene Therapy 6: 1415-1426, 1994.
22. Black ME, Rechtin TM and Drake RR: Effect on substrate binding of an alteration at the conserved aspartic acid-162 in herpes simplex virus type 1 thymidine kinase. J Gen Virol 77: 1521-1527, 1996.
23. Balasubramaniam NK, Veerisetty V and Gentry GA: Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation. Genl Virol 71: 2979-2987, 1990.